BIAFW

About bioAffinity Technologies, Inc.

bioAffinity Technologies, Inc. functions as an emerging entity focused on developing innovative solutions for the critical need in non-intrusive, early cancer detection and therapeutic interventions. The firm constructs distinctive in-vitro diagnostic instruments and targeted cancer treatments, employing cutting-edge technology engineered to specifically identify and attack cancerous cells. This company was established on March 26, 2014, with its principal offices situated in San Antonio, Texas.

CEO: Maria Zannes
IPO Date: Sep 1, 2022

Market Data

Open: $0.176
High: $0.176
Low: $0.1202
Volume: 52
Avg Volume: 2.1K
52W High: $0.47
52W Low: $0.1202

Valuation

Market Cap: $3.8M
Enterprise Value: $2.1M
Dividend Yield: 0.00%

Financials

Free Cash Flow: $-9.4M
Revenue: $6.2M
Net Income: $-15M
Cash: $6.4M
Debt: $1.2M

Events

EarningsAug 19

EPS est. -2.1